摘要
目的探讨重症急性胰腺炎(SAP)的早期预测与治疗.方法本组125例均行手术治疗,1997年3月～2000年3月71例SAP,按照APACHEⅡ标准诊断为SAP,2001年3月～2004年3月54例急性胰腺炎(AP)先行抗坏血酸(ascorbic acid,AA)水平预测SAP,并行综合疗法,其中50例(93%)发展成SAP作为治疗组.结果研究表明,治疗组能减少并发症,降低死亡率,缩短住院天数.结论依照AA预测SAP及早行综合疗法非手术治疗SAP,有潜在的临床应用价值.
Objective： To explore the early prediction of SAP and treatment, Methods： 125 cases with SAP were treated in ICU from March, 1997 to March, 2004. 71 eases with SAP were diagnosed with APACHE Ⅱ from March, 1997 to March, 2000,54 cases with AP firstly were preeonceiced patients with SAP by the level of AA and later 50 cases （93% of 54 eases） with AP proved to be SAP. Result： In the treatment group the length of hospitalization were siginificandy shorter, the reduction of complications and the increases of survival could be observed. Conclusion： Early diagnosis by AA and combined modality therapy may be a new way for treating SAP and it has potential clinical application.
出处
《泰山医学院学报》
CAS
2005年第4期329-330,共2页
Journal of Taishan Medical College
关键词
胰腺炎
抗坏血酸
综合疗法
severe acute pancreatitis,
as c orbit acid
combined modality therapy
